{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:11:03Z","timestamp":1793837463420,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020964","name":"Japan Science and Technology Agency Fusion Oriented REsearch for disruptive Science and Technology","doi-asserted-by":"publisher","award":["JPMJFR226J"],"award-info":[{"award-number":["JPMJFR226J"]}],"id":[{"id":"10.13039\/501100020964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006062","name":"Foundation for Promotion of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004091","name":"Kumamoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2127"],"award-info":[{"award-number":["JPMJSP2127"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.151992","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:29:09Z","timestamp":1746988149000},"page":"151992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Auranofin resensitizes ferroptosis-resistant lung cancer cells to ferroptosis inducers"],"prefix":"10.1016","volume":"770","author":[{"given":"Hao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-3882","authenticated-orcid":false,"given":"Toshiro","family":"Moroishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151992_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2025.151992_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.151992_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbrc.2025.151992_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.151992_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"Relli","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2025.151992_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.151992_bib7","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.bbrc.2025.151992_bib8","article-title":"Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151992_bib9","first-page":"3001","article-title":"Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis","volume":"17","author":"Pan","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2025.151992_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.bbrc.2025.151992_bib11","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1878-0261.12936","article-title":"Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-Mitochondrial fission-mitophagy axis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2025.151992_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151992_bib13","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.1821323116","article-title":"Cystine\/Glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance","volume":"116","author":"Lim","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.151992_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151992_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2025.151992_bib16","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.151992_bib17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/cas.13309","article-title":"Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer","volume":"108","author":"Otsubo","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2025.151992_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151992_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/carcin\/bgad020","article-title":"Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice","volume":"44","author":"Bagherpoor","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2025.151992_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195151","article-title":"Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma","volume":"13","author":"Nagane","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151992_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150373","article-title":"Cell attachment defines sensitivity to cold stress via the Hippo pathway","volume":"730","author":"Li","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151992_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","article-title":"Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment","volume":"24","author":"Ackerman","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151992_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ceb.2017.05.006","article-title":"Metabolism shapes the tumor microenvironment","volume":"48","author":"Reina-Campos","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151992_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/1541-7786.MCR-20-0534","article-title":"The Hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2","volume":"19","author":"Yang","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151992_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151992_bib26","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","article-title":"The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma","volume":"28","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2025.151992_bib27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2147\/OTT.S157058","article-title":"The role of Hippo signal pathway in breast cancer metastasis","volume":"11","author":"Wei","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2025.151992_bib28","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1242\/dev.070987","article-title":"Hippo pathway regulation by cell morphology and stress fibers","volume":"138","author":"Wada","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.bbrc.2025.151992_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151992_bib30","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1038\/s41467-018-07450-0","article-title":"Mediated nuclear import and export of TAZ and the underlying molecular requirements","volume":"9","author":"Kofler","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151992_bib31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.151992_bib32","first-page":"173","article-title":"The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis","volume":"8","author":"Katz","year":"1982","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.bbrc.2025.151992_bib33","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2015-07-660365","article-title":"Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma","volume":"126","author":"Celegato","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.151992_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7444","article-title":"Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy","volume":"10","author":"Stafford","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.151992_bib35","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2025.151992_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jjco\/hyy013","article-title":"Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma","volume":"48","author":"Hiyama","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.151992_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00280-013-2366-8","article-title":"Targeting cisplatin-resistant human tumor cells with metabolic inhibitors","volume":"73","author":"Sullivan","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151992_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41420-023-01463-5","article-title":"Drug-induced lactate confers ferroptosis resistance via p38-SGK1-NEDD4L-dependent upregulation of GPX4 in NSCLC cells","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2025.151992_bib39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"Panciera","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151992_bib40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.151992_bib41","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1038\/s41467-024-47423-0","article-title":"Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer","volume":"15","author":"Haderk","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151992_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/embj.201386082","article-title":"Tumor-propagating cells and Yap\/Taz activity contribute to lung tumor progression and metastasis","volume":"33","author":"Lau","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2025.151992_bib43","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2014.59.3590","article-title":"R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability","volume":"33","author":"Chen","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.151992_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.151992_bib45","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"Fiskus","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.151992_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165207","article-title":"Anti-cancer effects of auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels","volume":"27","author":"Cui","year":"2022","journal-title":"Molecules"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:10:52Z","timestamp":1781701852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0006291X25007065"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151992","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Auranofin resensitizes ferroptosis-resistant lung cancer cells to ferroptosis inducers","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151992"}}